MYLAN INSTITUTIONAL FDA Approval ANDA 203624

ANDA 203624

MYLAN INSTITUTIONAL

FDA Drug Application

Application #203624

Application Sponsors

ANDA 203624MYLAN INSTITUTIONAL

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INTRAVENOUS6GM/30ML (200MG/ML)0ACETYLCYSTEINEACETYLCYSTEINE

FDA Submissions

UNKNOWN; ORIG1AP2015-06-19
LABELING; LabelingSUPPL2AP2019-08-21STANDARD
LABELING; LabelingSUPPL3AP2019-08-21STANDARD
LABELING; LabelingSUPPL4AP2020-09-04STANDARD

Submissions Property Types

ORIG1Null15
SUPPL2Null7
SUPPL3Null7
SUPPL4Null15

CDER Filings

MYLAN INSTITUTIONAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203624
            [companyName] => MYLAN INSTITUTIONAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"ACETYLCYSTEINE","activeIngredients":"ACETYLCYSTEINE","strength":"6GM\/30ML (200MG\/ML)","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/19\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"09\/04\/2020","submission":"SUPPL-4","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"08\/21\/2019","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"08\/21\/2019","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-09-04
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.